Codexis与Axolabs签署评估协议 拓展Eco Synthesis®寡核苷酸治疗药物生产平台应用范围

美股速递
Jan 07

生物技术公司Codexis宣布与Axolabs达成评估协议,将针对寡核苷酸治疗药物领域拓展其Eco Synthesis®生产平台的应用范围。该合作标志着Codexis在药物生产技术创新方面迈出重要一步,通过平台技术的外部验证进一步强化行业影响力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10